Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XERT: Cetuximab, Capecitabine and Radiotherapy in Rectal Cancer
NCT00689702Phase 2Unknown
- Sponsor
- Institute of Oncology Ljubljana
- Start
- Feb 2007
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in rectal cancer, sponsored by Institute of Oncology Ljubljana. Status: unknown.
02
Drugs
KL-140
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00689702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00689702.